Contineum Therapeutics (CTNM) Times Interest Earned (2023 - 2026)
Contineum Therapeutics' (CTNM) quarterly Times Interest Earned came in at -$0.7 in Q1 2026, up 77.06% year-on-year from -$0.4 in Q1 2025, and up 96.5% quarter-over-quarter from -$20.06 in Q4 2025.
Contineum Therapeutics (CTNM) Times Interest Earned (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Times Interest Earned history runs 4 years deep, the most recent figure standing at -$0.7 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 77.06% year-over-year to -$0.7 in Q1 2026; TTM through Mar 2026 was -$2.78, a 72.19% increase from a year earlier, with the FY2025 full-year figure at -$1.42, up 0.88% from the prior year.
- Times Interest Earned grew to -$0.7 in Q1 2026 per CTNM's latest filing, from -$20.06 in the prior quarter.
- Across five years, Times Interest Earned topped out at $335.66 in Q2 2023 and bottomed at -$135.29 in Q4 2024.
- The 4-year median for Times Interest Earned is -$3.06 (2025), against an average of $12.63.
- Across the five-year window, Times Interest Earned surged 99.34% in 2024 and slumped 733.87% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $335.66 in 2023, then slumped by 140.31% to -$135.29 in 2024, then jumped by 85.17% to -$20.06 in 2025, then jumped by 96.5% to -$0.7 in 2026.
- Per Business Quant, the three latest CTNM Times Interest Earned figures stand at -$0.7 (Q1 2026), -$20.06 (Q4 2025), and -$0.75 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - | -0.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.70 |
| Dec 31, 2025 | -20.06 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -6.16 |
| Mar 31, 2025 | -3.06 |
| Dec 31, 2024 | -135.29 |
| Mar 31, 2024 | -0.37 |
| Jun 30, 2023 | 335.66 |
| Mar 31, 2023 | -55.60 |